AMEND wishes to support research and is provides grants when funds allow to enable medical researchers to supplement an existing project or pump-prime new research ideas. Applicants must be registered members of AMEND and the successful projects must be specifically directed to the study of endocrine tumours, within the context of the Charity’s remit (MEN1, MEN2, MEN3, PPGLs, ACC, spMTC).  Awards are only available to projects carried out within the United Kingdom and Eire.  Each project grant is usually worth up to £10,000, although larger amounts have been awarded.  Commonly, up to 3 project grants are available annually, although this can vary according to surplus funds available*.

*Research Awards for MEN/PGL Syndromes

AMEND is currently working on strengthening the sustainability of the charity, which includes finding ways to diversify income streams and recruit new or additional members of staff.  Together with challenges in income generation caused by the current financial climate, this means that the general Research Awards were suspended for 2023 and 2024 by the Board of Trustees at their meeting on 25th March 2023 (unless substantial funds are sourced in the meantime).  We apologise for any inconvenience this may cause, however, the Trustees feel that the securing the future of the charity is a bigger priority at present.

For further information and criteria, please view the application form:

NIHR Non-Commercial Partnership

AMEND is a National Institute for Health Research (NIHR) non-commercial Partner. This means the studies that we fund may be eligible to access the NIHR Study Support Service which is provided by the NIHR Clinical Research Network. The NIHR Clinical Research Network can now support health and social care research taking place in non-NHS settings, such as studies running in care homes or hospices, or public health research taking place in schools and other community settings. Read the full policy: Eligibility Criteria for NIHR Clinical Research Network Support.

In partnership with your local R&D office, we encourage you to involve your local NIHR Clinical Research Network team in discussions as early as possible when planning your study. This will enable you to fully benefit from the support available through the NIHR Study Support Service. To find out more, please visit: www.nihr.ac.uk/study-support-service

If your study involves NHS sites in England you will need to apply for Health Research Authority Approval. For guidance on submitting an application please visit: www.hra.nhs.uk.

Current and Past Award(s)